Skip to content

New: Flow X-Ray is live. Open the X-ray

Loading prices…

JPMorgan raises Teva stock price target to $50 on Weltruza approval

First reported 12 Oct, 10:20 amReported byInvesting.com
Read the full story on Investing.com
Key figures$50

Coverage and sources

1 source
  1. Investing.com ·

    JPMorgan raises Teva stock price target to $50 on Weltruza approval